In most jurisdictions it is sold and labeled "for research use only," and it is not a legal dietary supplement or medicine
People with type 2 diabetes using GLP-1 receptor agonists, DPP-IV inhibitors or multiple therapies combining metformin, sulfonylureas, repaglinide, alpha-glucosidase inhibitors or thiazolidinediones from 2006 to 2018 were included
Bykova A, Serova M, Chashkina M et al (2024) Glucagon-like peptide-1 receptor agonists in the context of pathophysiology of diverse heart failure with preserved ejection fraction phenotypes: potential benefits and mechanisms of action
They include genetics, ageing, and lifestyle elements like insufficient sleep, stress, and poor nutrition
We do not allow salon-trained therapists to deliver injectables, regardless of the product
This test maps 14 metabolic pathways and analyzes key variants such as GIPR rs1800437, which influence how your body responds to semaglutide and other peptide therapies